🔎 Trials Near Me

Utama › Dermatitis Atopik (Eksim) › Ohio

Kajian klinikal Dermatitis Atopik (Eksim) di Ohio

10 kajian untuk Dermatitis Atopik (Eksim) sedang mencari peserta di lokasi di Ohio.

Bandar di Ohio

Teks kajian rasmi (Bahasa Inggeris)

This Study is a Non-interventional Disease Registry of Adolescent and Adult Patients With Atopic Dermatitis Who Initiate or Switch Any Systemic Treatment

  • Dermatology Associates of Mid-Ohio- Site Number : 8400026, Marion
  • Dermatologists of Southwest Ohio - Mason- Site Number : 8400050, Mason
Mengambil pesertaKajian pemerhatian
Umur 12 ke atas · Semua jantina · Dikemas kini 29 Sep 2026 · NCT07290803

Study of ENV-294 in Adults With Moderate-to-Severe Atopic Dermatitis

  • Enveda Investigative Site, Canton
  • Enveda Investigative Site, Mayfield Heights
Mengambil pesertaFasa 2
Umur 18 hingga 75 · Semua jantina · Dikemas kini 25 Sep 2026 · NCT07298395

A Study to Learn About Study Medicine Called PF-08049820 in People With Eczema

  • Apex Clinical Research Center, LLC., Mayfield Heights
Mengambil pesertaFasa 2
Umur 18 hingga 64 · Semua jantina · Dikemas kini 25 Sep 2026 · NCT07216027

A Long-term Safety and Efficacy Study Evaluating APG777 in Atopic Dermatitis

  • Investigational Site, Boardman
  • Investigational Site, Mason
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 23 Sep 2026 · NCT07003425

A Phase 2b Study of the Effects of Camoteskimab in Adults With Moderate-to-Severe Atopic Dermatitis

  • ClinOhio Research Services, Columbus
Mengambil pesertaFasa 2
Umur 18 hingga 65 · Semua jantina · Dikemas kini 28 Ogo 2026 · NCT07599813

A Study to Evaluate the Efficacy and Safety of IMG-007 in Adult Participants With Moderate-to-Severe Atopic Dermatitis

  • Inmagene Site 9, Columbus
  • Inmagene Site 5, Mayfield Heights
Mengambil pesertaFasa 2
Umur 18 hingga 74 · Semua jantina · Dikemas kini 12 Ogo 2026 · NCT07037901

A Study to Assess Adverse Events and Change in Disease Activity Comparing Oral Upadacitinib to Subcutaneous Dupilumab in Children From 2 to Less Than 12 Years of Age With Moderate to Severe Atopic Dermatitis

  • DOCS Clinical Research - Canal Winchester /ID# 268271, Canal Winchester
  • Wright State Physicians Health Center /ID# 268841, Fairborn
Mengambil pesertaFasa 3
Umur 2 hingga 11 · Semua jantina · Dikemas kini 6 Ogo 2026 · NCT06461897

Targeted Investigation of Microbiome 2 Treat Atopic Dermatitis (TIME-2)

  • Cincinnati Children's Hospital Medical Center: Asthma Center, Cincinnati
Mengambil pesertaFasa 1
Umur 6 ke atas · Semua jantina · Dikemas kini 2 Jul 2026 · NCT06504160

A Study To Learn About Two Study Medicines (PF-07275315 And PF-07264660) In People Who Have Moderate To Severe Atopic Dermatitis

  • Apex Clinical Research Center, Mayfield Heights
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 4 Mei 2026 · NCT05995964

Real-world Experience Using Nemolizumab in the Treatment of Moderate-to-Severe Atopic Dermatitis in Adolescents & Adults

  • Galderma Investigational Site 7081, Dayton
Mengambil pesertaKajian pemerhatian
Umur 12 ke atas · Semua jantina · Dikemas kini 13 Mac 2026 · NCT06988605

Daripada ClinicalTrials.gov, data diperoleh pada 4 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.